Sitemap > Breaking Research > Cardiovascular Disorders
Displaying 451 - 500 of 4862 results
- Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction.
- 5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and Xa.
- N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity.
- Discovery of novel tetrahydroisoquinoline derivatives as potent and selective factor Xa inhibitors.
- Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
- Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice.
- Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation.
- Anti-angiogenic effects of SN38 (active metabolite of irinotecan): inhibition of hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) expression of glioma and growth of endothelial cells.
- Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
- Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3.
- Effects of Y-27632, a selective Rho-kinase inhibitor, on myocardial preconditioning in anesthetized rats.
- Conversion from cyclosporine to tacrolimus after renal transplantation improves cardiovascular risk factors.
- Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.
- Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.
- Reduction of infarct size and postischemic inflammation from ATL-146e, a highly selective adenosine A2A receptor agonist, in reperfused canine myocardium.
- Effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on cardiovascular alterations in endotoxemia.
- CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
- Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both.
- Risk of ischaemic stroke in people with migraine: systematic review and meta-analysis of observational studies.
- Synchronized infection of cell cultures by magnetically controlled virus.
- Treatment of coronary artery disease in dialysis patients with sirolimus-eluting stents: 1-year clinical follow-up of a consecutive series of cases.
- Discovery of inhibitors of MCF-7 tumor cell adhesion to endothelial cells and investigation on their mode of action.
- Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
- Trends in hypertension-related death in the United States: 1980-1998.
- Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease.
- Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.
- Inflammatory markers and the risk of coronary heart disease in men and women.
- Risk of myocardial infarction and stroke after acute infection or vaccination.
- Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
- Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonists.
- Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor.
- Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents.
- Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes.
- Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
- Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.
- Aquaporin-2 water channels in spontaneously hypertensive rats.
- A novel class of fusion polypeptides inhibits exocytosis.
- Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing.
- Protective role of angiopoietin-1 in endotoxic shock.
- Subclinical peripheral arterial disease in patients with chronic kidney disease: prevalence and related risk factors.
- Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice.
- Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.
- Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
- Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system.
- Smooth muscle cell expression of a constitutive active form of human Rac 1 accelerates cutaneous wound repair.
- A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.
- Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MI.
- Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
- Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. primary care setting.
- Accurate multiplex gene synthesis from programmable DNA microchips.
< Previous 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 Next >